Skip to main content

Where are we with nuclear medicine in pediatrics?

European Journal of Nuclear Medicine volume 22, pages 1433–1451 (1995)Cite this article

Abstract

The practice of nuclear medicine in children is different from that in adults. Technical considerations including immobilization, dosing of radiopharmaceuticals, and instrumentation are of major importance. Image magnification and the capability to perform singlephoton emission tomography are essential to performing state of the art pediatric nuclear medicine. New advances in instrumentation with multiple detector imaging, the possibility of clinical positron emission tomography imaging in children, and new radiopharmaceuticals will further enhance pediatric scintigraphic imaging. This review highlights advances in pediatric nuclear medicine and discusses selected clinical problems.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

References

  1. Conway JJ, guest ed. Pediatric nuclear medicine part I and II.Semin Nucl Med 1993; 23: 187–346.

    Google Scholar 

  2. Piepsz A, Gordon I, Hahn K. Paediatric nuclear medicine.Eur J Nucl Med 1991; 18: 41–66.

    Google Scholar 

  3. Piepsz A. Recent advances in pediatric nuclear medicine.Semin Nucl Med 1995; 25: 165–182.

    Google Scholar 

  4. Miller JH, Gelfand MJ.Pediatric nuclear imaging. Philadelphia: Saunders, 1994.

    Google Scholar 

  5. Treves ST.Pediatric nuclear medicine. Berlin Heidelberg New York: Springer, 1995.

    Google Scholar 

  6. Murray IPC, Ell PJ.Nuclear medicine in clinical diagnosis and treatment. New York: Churchill Livingstone, 1994.

    Google Scholar 

  7. Weiss S. Sedation of pediatric patients for nuclear medicine procedures [review].Semin Nucl Med 1993; 23: 190–198.

    Google Scholar 

  8. Pintelon H, Jonckheer MH, Piepsz A. Paediatric nuclear medicine procedures: routine sedation or management of anxiety?Nucl Med Commun 1994; 15: 664–666.

    Google Scholar 

  9. American Academy of Pediatrics Committee on Drugs: guidelines for monitoring and management of pediatric patients during and after sedation for diagnostic and therapeutic procedures.Pediatrics 1992; 89: 1110–1115.

    Google Scholar 

  10. Davis RT, Zimmerman RE, Treves ST. Magnification in pediatric nuclear medicine. In: Treves ST, ed.Pediatric nuclear medicine. Berlin Heidelberg New York: Springer; 1995: 24–32.

    Google Scholar 

  11. Spence LD, Kaar K, McCabe J, O'Neill M. The role of bone scintigraphy with pinhole collimation in the evaluation of symptomatic paediatric hips.Clin Radiol 1994; 49: 820–823.

    Google Scholar 

  12. Sty JR, Wells RG, Conway JJ. Spine pain in children.Semin Nucl Med 1993; 23: 296–320.

    Google Scholar 

  13. Jaszczak RJ, Murphy PH, Huard D, Burdine JA. Radionuclide emission computed tomography of the head with99mTc and a scintillation camera.J Nucl Med 1977; 18: 373–380.

    Google Scholar 

  14. Iosilevsky G, Israel O, Frenkel A, Even-Sapir E, Ben-Haim S, Front A, Kolodny GM, Front D. A practical SPECT technique for quantitation of drug delivery to human tumors and organ absorbed radiation dose.Semin Nucl Med 1989; 19: 33–46.

    Google Scholar 

  15. Groshar D, Moskovitz B, Gorenberg M, Frankel A, Jerusalmi J, Livne PM, Front D. Quantitative SPECT of technetium-99m-DMSA uptake in the kidneys of normal children and in kidneys with vesicoureteral reflux: detection of unilateral kidney disease.J Nucl Med 1994; 35: 445–449.

    Google Scholar 

  16. Tsui BM, Zhao X, Frey EC, McCartney WH. Quantitative single-photon emission computed tomography: basics and clinical considerations.Semin Nucl Med 1994; 24: 38–65.

    Google Scholar 

  17. Even-Sapir E, Bar-Shalom R, Israel O, Frenkel A, Iosilevsky G, Haim N, Epelbaum R, Gaitini D, Kolodny GM, Front D. Single-photon emission computed tomography quantitation of gallium citrate uptake for the differentiation of lymphoma from benign hilar uptake.J Clin Oncol 1995; 13: 942–946.

    Google Scholar 

  18. Groch MW, Erwin WD, Bieszk JA. Single-photon emission computed tomography. In: Treves ST, ed.Pediatric nuclear medicine. Berlin Heidelberg New York: Springer; 1995: 33–87.

    Google Scholar 

  19. Buscombe JR, Townsend CE, Kouris K, Clarke G, Mahmood S, Jarritt PH, Ell PJ. Clinical high resolution skeletal singlephoton emission tomography using a triple-headed gamma camera.Br J Radiol 1993; 66: 817–822.

    Google Scholar 

  20. MacIntyre WJ, Saha GB, Go RT. Planar imaging with singlehead large-field-of-view cameras: are they still the workhorse? [review].Semin Nucl Med 1994; 24: 11–16.

    Google Scholar 

  21. Front D, Bar-Shalom R, Iosilevsky G, Frenkel A, Gorenberg M, Kolodny GM, Israel O. Ga-67 scintigraphy with a dualhead camera.Clin Nucl Med 1995; 20: 542–548.

    Google Scholar 

  22. Datz FL, Gullberg GT, Zeng GL, Tung CH, Christian PE, Welch A, Clack R. Application of convergent-beam collimation and simultaneous transmission emission tomography to cardiac single-photon emission computed tomography.Semin Nucl Med 1994; 24: 17–37.

    Google Scholar 

  23. Lang TF, Hasegawa BH, Liew SC, Brown JK, Blankespoor SC, Reilly SM, Gingold EL, Cann CE. Description of a prototype emission-transmission computed tomography imaging system.J Nucl Med 1992; 33: 1881–1887.

    Google Scholar 

  24. Cao Z, Tsui BM. Performance characteristics of transmission imaging using a uniform sheet source with parallel-hole collimation.Med Phys 1992; 19: 1205–1212.

    Google Scholar 

  25. Tan P, Bailey DL, Meikle SR, Eberl S, Fulton RR, Hutton BF. A scanning line source for simultaneous emission and transmission measurements in SPECT.J Nucl Med 1993; 34: 1752–1760.

    Google Scholar 

  26. West JH, Seymour JC, Drane WE. Combined transmissionemission imaging in lymphoscintigraphy.Clin Nucl Med 1993; 18: 762–764.

    Google Scholar 

  27. Bonnin F, Buvat I, Benali H, Di Paola R. A comparative study of scatter correction methods for scintigraphic images.Eur J Nucl Med 1994; 21: 388–393.

    Google Scholar 

  28. Floyd JL, Mann RB, Shaw A. Changes in quantitative SPECT201Tl results associated with the use of energy-weighted acquisition.J Nucl Med 1991; 32: 805–807.

    Google Scholar 

  29. DeVito RP, Hamill JJ, Treffert JD, Stoub EW. Energy-weighted acquisition of scintigraphic images using finite spatial filters.J Nucl Med 1989; 30: 2029–2035.

    Google Scholar 

  30. DeVito RP, Hamill JJ. Determination of weighting functions for energy-weighted acquisition.J Nucl Med 1991; 32: 343–349.

    Google Scholar 

  31. Ichihara T, Ogawa K, Motomura N, Kubo A, Hashimoto S. Compton scatter compensation using the triple-energy window method for single- and dual-isotope SPECT.J Nucl Med 1993; 34: 2216–2221.

    Google Scholar 

  32. Rao MG. Bone imaging with energy-weighted acquisition.J Nucl Med 1993; 34: 997–999.

    Google Scholar 

  33. Chugani HT. The role of PET in childhood epilepsy.J Child Neurol 1994; 9 Suppl 1: S82–88.

    Google Scholar 

  34. Chugani HT, Jacobs B. Metabolic recovery in caudate nucleus of children following cerebral hemispherectomy.Ann Neurol 1994; 36: 794–797.

    Google Scholar 

  35. Duncan DB, Herholz K, Kugel H, Roth B, Ruitenbeek W, Heindel W, Wienhard K, Heiss WD. Positron emission tomography and magnetic resonance spectroscopy of cerebral glycolysis in children with congenital lactic acidosis.Ann Neurol 1995; 37: 351–358.

    Google Scholar 

  36. Ehrich JH, Burchert W, Schirg E, Krull F, Offner G, Hoyer PF, Brodehl J. Steroid resistant nephrotic syndrome associated with spondyloepiphyseal dysplasia, transient ischemic attacks and lymphopenia.Clin Nephrol 1995; 43: 89–95.

    Google Scholar 

  37. Ikezaki K, Matsushima T, Kuwabara Y, Suzuki SO, Nomura T, Fukui M. Cerebral circulation and oxygen metabolism in childhood moyamoya disease: a perioperative positron emission tomography study.J Neurosurg 1994; 81: 843–850.

    Google Scholar 

  38. Shulkin BL, Mitchell DS, Ungar DR, Prakash D, Dole MG, Castle VP, Hernandez RJ, Koeppe RA, Hutchinson RJ. Neoplasms in a pediatric population: 2- [F-18]-fluoro-2-deoxy-d-glucose PET studies.Radiology 1995; 194: 495–500.

    Google Scholar 

  39. Worley G, Hoffman JM, Paine SS, Kalman SL, Claerhout SJ, Boyko OB, Kandt RS, Santos CC, Hanson MW, Oakes WJ, Coleman RE. 18-Fluorodeoxyglucose positron emission tomography in children and adolescents with traumatic brain injury.Dev Med Child Neurol 1995; 37: 213–220.

    Google Scholar 

  40. Van Lingen A, Huijgens PC, Visser FC, Ossenkoppele GJ, Hoekstra OS, Martens HJ, Huitink H, Herscheid KD, Green MV, Teule GJ. Performance characteristics of a 511-keV collimator for imaging positron emitters with a standard gammacamera.Eur J Nucl Med 1992; 19: 315–321.

    Google Scholar 

  41. Drane WE, Abbott FD, Nicole MW, Mastin ST, Kuperus JH. Technology for FDG SPECT with a relatively inexpensive gamma camera. Work in progress.Radiology 1994; 191: 461–465.

    Google Scholar 

  42. Mukherji SK, Drane WE, Tart RP, Landau S, Mancuso AA. Comparison of201Tl and F-18 FDG SPECT uptake in squamous cell carcinoma of the head and neck.AJNR Am J Neuroradiol 1994; 15: 1837–1842.

    Google Scholar 

  43. Holman BL, Zimmerman RE, Johnson KA, Carvalho PA, Schwartz RB, Loeffler JS, Alexander E, Pelizzari CA, Chen GT. Computer-assisted superimposition of magnetic resonance and high-resolution technetium-99m-HMPAO and201TL SPECT images of the brain.J Nucl Med 1991; 32: 1478–1484.

    Google Scholar 

  44. Kramer EL, Noz ME. CT-SPECT fusion for analysis of radiolabeled antibodies: applications in gastrointestinal and lung carcinoma.Int J Rad Appl Instrum [B] 1991; 18: 27–42.

    Google Scholar 

  45. Loats H. CT and SPECT image registration and fusion for spatial localization of metastatic processes using radiolabeled monoclonals.J Nucl Med 1993; 34: 562–566.

    Google Scholar 

  46. Scott AM, Macapinlac HA, Divgi CR, Zhang JJ, Kalaigian H, Pentlow K, Hilton S, Graham MC, Sgouros G, Pelizzari C, Chen G, Schlom J, Goldsmith SJ, Larson SM. Clinical validation of SPECT and CT/MRI image registration in radiolabeled monoclonal antibody studies of colorectal carcinoma.J Nucl Med 1994; 35: 1976–1984.

    Google Scholar 

  47. Weber DA, Ivanovic M. Correlative image registration.Semin Nucl Med 1994; 24: 311–323.

    Google Scholar 

  48. Barber DC. Registration of low resolution medical images.Phys Med Biol 1992; 37: 1485–1498.

    Google Scholar 

  49. Scott AM, Macapinlac H, Zhang J, Daghighian F, Montemayor N, Kalaigian H, Sgouros G, Graham MC, Kolbert K, Yeh SDJ, Lai E, Goldsmith SJ, Larson SM. Image registration of SPECT and CT images using an external fiduciary band and three-dimensional surface fitting in metastatic thyroid cancer.J Nucl Med 1995; 36: 100–103.

    Google Scholar 

  50. Lange N. Some computational and statistical tools for paired comparisons of digital images.Stat Methods Med Res 1994; 3: 23–40.

    Google Scholar 

  51. Pietrzyk U, Herholz K, Fink G, Jacobs A, Mielke R, Slansky I, Wurker M, Heiss WD. An interactive technique for three-dimensional image registration: validation for PET, SPECT, MRI and CT brain studies.J Nucl Med 1994; 35: 2011–2018.

    Google Scholar 

  52. Todd-Pokropek AE. Functional imaging of the brain using single-photon emission computerized tomography (SPECT).Brain Topogr 1992; 5: 119–127.

    Google Scholar 

  53. Faber TL, McColl RW, Opperman RM, Corbett JR, Peshock RM. Spatial and temporal registration of cardiac SPECT and MRI images: methods and evaluation.Radiology 1991; 179: 857–861.

    Google Scholar 

  54. Slomka PJ, Hurwitz GA, Stephenson J, Cradduck T. Automated alignment and sizing of myocardial stress and rest scans to three-dimensional normal templates using an image registration algorithm.J Nucl Med 1995; 36: 1115–1122.

    Google Scholar 

  55. Andersson JLR, Sundin A, Valind S. A method for coregistration of PET and MRI brain images.J Nucl Med 1995; 36: 1307–1315.

    Google Scholar 

  56. Biersack HJ, Briele B, Hotze AL, Oehr P, Qian L, Mekkawy MA, Shih WJ. The role of nuclear medicine in oncology.Ann Nucl Med 1992; 6: 131–136.

    Google Scholar 

  57. Cogswell A, Howman-Giles R, Bergin M. Bone and gallium scintigraphy in children with rhabdomyosarcoma: a 10-year review.Med Pediatr Oncol 1994; 22: 15–21.

    Google Scholar 

  58. Bekerman C, Port RB, Pang E, Moohr JW, Kranzler JK. Scintigraphic evaluation of childhood malignancies by67Ga-citrate.Radiology 1978; 127: 719–725.

    Google Scholar 

  59. Bitran JD, Bekerman C, Golomb HM, Simon MA. Scintigraphic evaluation of sarcomata in children and adults by Ga67 citrate.Cancer 1978; 42: 1760–1765.

    Google Scholar 

  60. Yang SL, Alderson PO, Kaizer HA, Wagner HN Jr. Serial67Ga citrate imaging in children with neoplastic disease: concise communication.J Nucl Med 1979; 20: 210–214.

    Google Scholar 

  61. Howman-Giles R, Stevens M, Bergin M. Role of gallium-67 in management of paediatric solid tumors.Aust Paediatr J. 1982; 18: 120–125.

    Google Scholar 

  62. Edeling CJ.67Ga imaging in pediatric oncology.Clin Nucl Med 1983; 8: 205–209.

    Google Scholar 

  63. Bekerman C, Pavel DG, Bitran J, Ryo UY, Pinsky S. The effects of inadvertent administration of antineoplastic agents prior to67Ga injection: concise communication.J Nucl Med 1984; 25: 430–435.

    Google Scholar 

  64. Nadel HR, Rossleigh MA. Tumor imaging. In: Treves ST, ed.Pediatric nuclear medicine. Berlin Heidelberg New York: Springer; 1995: 496–527.

    Google Scholar 

  65. Rossleigh MA, Murray IP, Mackey DW, Bargwanna KA, Nayanar VV. Pediatric solid tumors: evaluation by gallium-67 SPECT studies.J Nucl Med 1990; 31: 168–172.

    Google Scholar 

  66. Aktolun C, Bayhan H, Kir M. Clinical experience with99mTc MIBI imaging in patients with malignant tumors. Preliminary results and comparison with Tl-201.Clin Nucl Med 1992; 17: 171–176.

    Google Scholar 

  67. Caner B, Kitapçi M, Unlü M, Erbengi G, Çalikoglu T, Gögüs T, Bekdik C. Technetium-99m MIBI uptake in benign and malignant bone lesions: a comparative study with technetium-99-MDP.J Nucl Med 1992; 33: 319–324.

    Google Scholar 

  68. Nadel HR. Thallium-201 for oncological imaging in children [review].Semin Nucl Med 1993; 23: 243–254.

    Google Scholar 

  69. Ando A, Ando I, Katayama M, Sanada S, Hiraki T, Mori H, Tonami N, Hisada K. Biodistributions of 201-thallium in tumor bearing animals and inflammatory lesion induced animals.Eur J Nucl Med 1987; 12: 567–572.

    Google Scholar 

  70. Crane P, Laliberté R, Heminway S, Thoolen M, Orlandi C. Effect of mitochondrial viability and metabolism on technetium-99m-sestamibi myocardial retention.Eur J Nucl Med 1993; 20: 20–25.

    Google Scholar 

  71. Ramanna L, Waxman A, Binney G, Waxman S, Mirra J, Rosen G. Thallium-201 scintigraphy in bone sarcoma: comparison with gallium-67 and technetium-MDP in the evaluation of chemotherapeutic response.J Nucl Med 1990; 31: 567–572.

    Google Scholar 

  72. Van Der Wall H, Murray IPC, Huckstep RL, Philips RL. The role of thallium scintigraphy in excluding malignancy in bone.Clin Nucl Med 1993; 18: 551–557.

    Google Scholar 

  73. O'Tuama LA, Janicek MJ, Barnes PD, Scott RM, Black PM, Sallan SE, Tarbell NJ, Kupsky WJ, Wagenaar D, Ulanski JS, Treves ST. 201Tl/99mTc-HMPAO SPECT imaging of treated childhood brain tumors.Pediatr Neurol 1991; 7: 249–257.

    Google Scholar 

  74. O'Tuama LA, Treves ST, Larar JN, Packard AB, Kwan AJ, Barnes PD, Scott RM, Black PM, Madsen JR, Goumnerova LC, Sallan SE, Tarbell NJ. Thallium-201 versus technetium-99m-MIBI SPECT in evaluation of childhood brain tumors: a within-subject comparison.J Nucl Med 1993; 34: 1045–1051.

    Google Scholar 

  75. Dierckx RA, Martin JJ, Dobbeleir A, Crols R, Neetens I, De Deyn PP. Sensitivity and specificity of201Tl single-photon emission tomography in the functional detection and differential diagnosis of brain tumours.Eur J Nucl Med 1994; 21: 621–633.

    Google Scholar 

  76. Maria BL, Drane WE, Quisling RG, Ringdahl DM, Mickle JP, Mendenhall NP, Marcus RB Jr, McCollough WM, Hamed LM, Eskin TA, Kedar A. Value of201Tl SPECT imaging in childhood brain tumors.Pediatr Neurosurg 1994; 20: 11–18.

    Google Scholar 

  77. Oriuchi N, Tamura M, Shibazaki T, Ohye C, Watanabe N, Tateno M, Tomiyoshi K, Hirano T, Inoue T, Endo K. Clinical evaluation of201Tl SPECT in supratentorial gliomas: relationship to histologic grade, prognosis and proliferative activities.J Nucl Med 1993; 34: 2085–2089.

    Google Scholar 

  78. Rollins NK, Lowry PA, Shapiro KN. Comparison of gadolinium-enhanced MR and201Tl single-photon emission computed tomography in pediatric brain tumors.Pediatr Neurosurg 1995; 22: 8–14.

    Google Scholar 

  79. Nadel HR, Frankel M, Chan KW, Stringer DA. Evaluation of Tl-201 scintigraphy in pediatric extremity osteogenic sarcoma [abstract].Radiology 1992; 185: 107.

    Google Scholar 

  80. Menendez LR, Fideler BM, Mirra J. Thallium-201 scanning for the evaluation of osteosarcoma and soft-tissue sarcoma. A study of the evaluation and predictability of the histological response to chemotherapy.J Bone Joint Surg [Am] 1993; 75: 526–531.

    Google Scholar 

  81. Rosen G, Loren GJ, Brien EW, Ramanna L, Waxman A, Lowenbraun S, Eckardt JJ, Eilber F, Menendez L, Mirra JM. Serial201Tl scintigraphy in osteosarcoma. Correlation with tumor necrosis after preoperative chemotherapy.Clin Orthop 1993; 293: 302–306.

    Google Scholar 

  82. Caluser CI, Abdel-Dayem HM, Macapinlac HA, Scott A, Healey JH, Huvos A, Kalaigian H, Yeh SD, Larson SM. The value of thallium and three-phase bone scans in the evaluation of bone and soft tissue sarcomas.Eur J Nucl Med 1994; 21: 1198–1205.

    Google Scholar 

  83. Howman-Giles R, Uren RF, Kellie SJ. Gallium and thallium scintigraphy in pediatric peripheral primitive neuroectodermal tumor (Askin tumor) of the chest wall.J Nucl Med 1995; 36: 814–816.

    Google Scholar 

  84. Lin J, Leung W-t, Ho SKW, Ho KC, Kumta SM, Metreweli C, Johnson PJ. Quantitative evaluation of201Tl uptake in predicting chemotherapeutic response of osteosarcoma.Eur J Nucl Med 1995; 22: 553–555.

    Google Scholar 

  85. Harris EW, Rakow JI, Weiner M, Agress H Jr. Thallium-201 scintigraphy for assessment of a gallium-67-avid mediastinal mass following therapy for Hodgkin's disease.J Nucl Med 1993; 34: 1326–1330.

    Google Scholar 

  86. Israel O, Front D. Benign mediastinal and parahilar uptake of gallium-67 in treated lymphoma: do we have all the answers?J Nucl Med 1993; 34: 1330–1332.

    Google Scholar 

  87. Cohen M, Hill CA, Cangir A, Sullivan M. Thymic rebound after treatment of childhood tumors.AJR Am J Roentgenol 1980; 135: 151–156.

    Google Scholar 

  88. Donahue DM, Leonard JC, Basmadjian GP, Nitschke RM, Hinkle GH, Ice RD, Wilson DA, Tunell WP. Thymic gallium-67 localization in pediatric patients on chemotherapy: concise communication.J Nucl Med 1981; 22: 1043–1048.

    Google Scholar 

  89. Nakajo M, Shapiro B, Copp J, Kalff V, Gross MD, Sisson JC, Beierwaltes WH. The normal and abnormal distribution of the adrenomedullary imaging agentm-[I-131]iodobenzylguanidine (I-131 MIBG) in man: evaluation by scintigraphy.J Nucl Med 1983; 24: 672–682.

    Google Scholar 

  90. Hattner RS, Huberty JP, Engelstad BL, Gooding CA, Ablin AR. Localization ofm-iodo(131I)benzylguanidine in neuroblastoma.AJR Am J Roentgenol 1984; 143: 373–374.

    Google Scholar 

  91. Geatti O, Shapiro B, Sisson JC, Hutchinson RJ, Mallette S, Eyre P, Beierwaltes WH. Iodine-131 metaiodobenzylguanidine scintigraphy for the location of neuroblastoma: preliminary experience in ten cases.J Nucl Med 1985; 26: 736–742.

    Google Scholar 

  92. Garty I, Friedman A, Sandler MP, Kedar A. Neuroblastoma: imaging evaluation by sequential99mTc-MDP, I-131 MIBG, and67Ga citrate studies.Clin Nucl Med 1989; 14: 515–522.

    Google Scholar 

  93. Gelfand MJ. Meta-iodobenzylguanidine in children [review].Semin Nucl Med 1993; 23: 231–242.

    Google Scholar 

  94. Maurea S, Lastoria S, Caraco C, Indolfi P, Casale F, di Tullio MT, Salvatore M. Iodine-131-MIBG imaging to monitor chemotherapy response in advanced neuroblastoma: comparison with laboratory analysis.J Nucl Med 1994; 35: 1429–1435.

    Google Scholar 

  95. Samuel AM, Murugesan S, Kurkure PA, Advani SH, Sonawane GA, Noronha OP.131I-MIBG scintigraphy in neural crest tumours.Indian J Cancer 1994; 31: 103–110.

    Google Scholar 

  96. Hoefnagel CA, Voute PA, de Kraker J, Marcuse HR. Radionuclide diagnosis and therapy of neural crest tumors using iodine-131 metaiodobenzylguanidine.J Nucl Med 1987; 28: 308–314.

    Google Scholar 

  97. Edeling CJ, Frederiksen PB, Kamper J, Jeppesen P. Diagnosis and treatment of neuroblastoma using metaiodobenzylguanidine.Clin Nucl Med 1987; 12: 632–637.

    Google Scholar 

  98. Matthay KK, Huberty JP, Hattner RS, Ablin AR, Engelstad BL, Zoger S, Hasegawa BH, Price D. Efficacy and safety of [131I]metaiodobenzylguanidine therapy for patients with refractory neuroblastoma.J Nucl Biol Med 1991; 35: 244–247.

    Google Scholar 

  99. Hoefnagel CA, De Kraker J, Valdes Olmos RA, Voute PA.131I-MIBG as a first-line treatment in high-risk neuroblastoma patients.Nucl Med Commun 1994; 15: 712–717.

    Google Scholar 

  100. Matthay KK. Neuroblastoma: a clinical challenge and biologic puzzle.CA Cancer J Clin 1995; 45: 179–192.

    Google Scholar 

  101. Mastrangelo R, Lasorella A, Troncone L, Rufini V, Iavarone A, Riccardi R. [131I]metaiodobenzylguanidine in neuroblastoma patients at diagnosis.J Nucl Biol Med 1991; 35: 252–254.

    Google Scholar 

  102. Paltiel HJ, Gelfand MJ, Elgazzar AH, Washburn LC, Harris RE, Masters PR, Golsch GJ. Neural crest tumors: I-123 MIBG imaging in children.Radiology 1994; 190: 117–121.

    Google Scholar 

  103. Gelfand MJ, Elgazzar AH, Kriss VM, Masters PR, Golsch GJ. Iodine-123-MIBG SPECT versus planar imaging in children with neural crest tumors.J Nucl Med 1994; 35: 1753–1757.

    Google Scholar 

  104. Lashford LS, Moyes J, Ott R, Fielding S, Babich J, Mellors S, Gordon I, Evans K, Kemshead JT. The biodistribution and pharmacokinetics of meta-iodobenzylguanidine in childhood neuroblastoma.Eur J Nucl Med 1988; 13: 574–577.

    Google Scholar 

  105. Parisi MT, Sandler ED, Hattner RS. The biodistribution of metaiodobenzylguanidine.Semin Nucl Med 1992; 22: 46–48.

    Google Scholar 

  106. Hattner RS, Pounds TR, Matthay KK. Normal cerebellar MIBG localization. Implications in the interpretation of delayed scans.Clin Nucl Med 1994; 19: 985–988.

    Google Scholar 

  107. Bonnin F, Lumbroso J, Tenenbaum F, Hartmann O, Parmentier C. Refining interpretation of MIBG scans in children.J Nucl Med 1994; 35: 803–810.

    Google Scholar 

  108. Wafelman AR, Hoefnagel CA, Maes RA, Beijnen JH. Radioiodinated metaiodobenzylguanidine: a review of its biodistribution and pharmacokinetics, drug interactions, cytotoxicity and dosimetry.Eur J Nucl Med 1994; 21: 545–559.

    Google Scholar 

  109. Shapiro B. Imaging of catecholamine-secreting tumours: uses of MIBG in diagnosis and treatment.Baillieres Clin Endocrinol Metab 1993; 7: 491–507.

    Google Scholar 

  110. Yeh SD, Helson L, Benua RS. Correlation between iodine-131 MIBG imaging and biological markers in advanced neuroblastoma.Clin Nucl Med 1988; 13: 46–52.

    Google Scholar 

  111. Ady N, Zucker JM, Asselain B, Edeline V, Bonnin F, Michon J, Gongora R, Manil L. A new123I-MIBG whole body scan scoring method — application to the prediction of the response of metastases to induction chemotherapy in stage IV neuroblastoma.Eur J Cancer 1995; 31A: 256–261.

    Google Scholar 

  112. Parisi MT, Matthay KK, Huberty JP, Hattner RS. Neuroblastoma: dose-related sensitivity of MIBG scanning in detection.Radiology 1992; 184: 463–467.

    Google Scholar 

  113. Parisi MT, Greene MK, Dykes TM, Moraldo TV, Sandler ED, Hattner RS. Efficacy of metaiodobenzylguanidine as a scintigraphic agent for the detection of neuroblastoma.Invest Radiol 1992; 27: 768–773.

    Google Scholar 

  114. Parisi MT, Hattner RS, Matthay KK, Berg BO, Sandler ED. Optimized diagnostic strategy for neuroblastoma in opsoclonus-myoclonus.J Nucl Med 1993; 34: 1922–1926.

    Google Scholar 

  115. Dessner DA, DiPietro MA, Shulkin BL. MIBG detection of hepatic neuroblastoma: correlation with CT, US and surgical findings.Pediatr Radiol 1993; 23: 276–280.

    Google Scholar 

  116. Englaro EE, Gelfand MJ, Harris RE, Smith HS. I-131 MIBG imaging after bone marrow transplantation for neuroblastoma.Radiology 1992; 182: 515–520.

    Google Scholar 

  117. Gordon I, Peters AM, Gutman A, Morony S, Dicks-Mireaux C, Pritchard J. Skeletal assessment in neuroblastoma — the pitfalls of iodine-123-MIBG scans.J Nucl Med 1990; 31: 129–134.

    Google Scholar 

  118. Berthold F, Waters W, Sieverts H, Linden A. Immunoscintigraphic imaging of mIBG-negative metastases in neuroblastoma.Am J Pediatr Hematol Oncol 1990; 12: 61–62.

    Google Scholar 

  119. Krenning EP, Bakker WH, Breeman WA, Koper JW, Kooij PP, Ausema L, Lameris JS, Reubi JC, Lamberts SW. Localisation of endocrine-related tumours with radioiodinated analogue of somatostatin.Lancet 1989; 1: 242–244.

    Google Scholar 

  120. Bakker WH, Krenning EP, Breeman WA, Koper JW, Kooij PP, Reubi JC, Klijn JG, Visser TJ, Docter R, Lamberts SW. Receptor scintigraphy with a radioiodinated somatostatin analogue: radiolabeling, purification, biologic activity, and in vivo application in animals.J Nucl Med 1990; 31: 1501–1509.

    Google Scholar 

  121. Lamberts SW, Bakker WH, Reubi JC, Krenning EP. Somatostatin-receptor imaging in the localization of endocrine tumors.N Engl J Med 1990; 323: 1246–1249.

    Google Scholar 

  122. Krenning EP, Bakker WH, Kooij PP, Breeman WA, Oei HY, de JM, Reubi JC, Visser TJ, Bruns C, Kwekkeboom DJ, Reijs AE, van Hagen PM, Koper JW, Lamberts SW. Somatostatin receptor scintigraphy with indium-111-DTPA-d-Phe-1-octreotide in man: metabolism, dosimetry and comparison with iodine-123-Tyr-3-octreotide.J Nucl Med 1992; 33: 652–658.

    Google Scholar 

  123. Krenning EP, Kwekkeboom DJ, de Jong M, Visser TJ, Reubi JC, Bakker WH, Kooij PP, Lamberts SW. Essentials of peptide receptor scintigraphy with emphasis on the somatostatin analog octreotide.Semin Oncol 1994; 21: 6–14.

    Google Scholar 

  124. Krenning EP, Kwekkeboom DJ, Pauwels S, Kvols LK, Reubi JC. Somatostatin receptor scintigraphy. In: Freeman LM, ed.Nuclear medicine annual. New York: Raven Press; 1995: 1–50.

    Google Scholar 

  125. Hoefnagel CA. Metaiodobenzylguanidine and somatostatin in oncology: role in the management of neural crest tumours.Eur J Nucl Med 1994; 21: 561–581.

    Google Scholar 

  126. Lauriero F, Rubini G, D'Addabbo F, Rubini D, Schettini F, D'Addabbo A. I-131 MIBG scintigraphy of neuroectodermal tumors. Comparison between I-131 MIBG and In-111 DTPA-octreotide.Clin Nucl Med 1995; 20: 243–249.

    Google Scholar 

  127. Dorr U, Sautter-Bihl ML, Schilling FH, Koscielniak E, Treuner J, Bihl H. Somatostatin receptor scintigraphy (SRS): a new diagnostic tool in neuroblastoma (NB)?Prog Clin Biol Res 1994; 385: 355–361.

    Google Scholar 

  128. Sautter-Bihl ML, Dorr U, Schilling F, Treuner J, Bihl H. Somatostatin receptor imaging: a new horizon in the diagnostic management of neuroblastoma.Semin Oncol 1994; 21: 38–41.

    Google Scholar 

  129. Manil L, Perdereau B, Barbaroux C, Brixy F. Strong uptake of111In-pentetreotide by an MIBG-negative, xenografted neuroblastoma.Int J Cancer 1994; 57: 245–246.

    Google Scholar 

  130. O'Dorisio MS, Hauger M, Cecalupo AJ. Somatostatin receptors in neuroblastoma: diagnostic and therapeutic implications.Semin Oncol 1994; 21: 33–37.

    Google Scholar 

  131. Krenning EP, Kwekkeboom DJ, Bakker WH, Breeman WAP, Kooij PPM, Oei HY, van Hagen M, Postema PTE, de Jong M, Reubi JC, Visser TJ, Reijs AEM, Hofland LJ, Koper JW, Lamberts SWJ. Somatostatin receptor scintigraphy with [111In-DTPA-d-Phel]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients.Eur J Nucl Med 1993; 20: 716–731.

    Google Scholar 

  132. O'Dorisio MS, Chen F, O'Dorisio TM, Wray D, Qualman SJ. Characterization of somatostatin receptors on human neuroblastoma tumors.Cell Growth Differ 1994; 5: 1–8.

    Google Scholar 

  133. Goldman A, Vivian G, Gordon I, Pritchard J, Kemshead J. Immunolocalization of neuroblastoma with radiolabeled monoclonal antibody UJ 13 A.J Pediatr 1984; 105: 252–260.

    Google Scholar 

  134. Scott AM, Larson SM. Tumor imaging and therapy.Radiol Clin North Am 1993; 31: 859–879.

    Google Scholar 

  135. Goldenberg DM, Schlom J. The coming of age of cancer radioimmunoconjugates.Immunol Today 1993; 14: 5–7.

    Google Scholar 

  136. De Jager R, Abdel-Nabi H, Serafini A, Pecking A, Klein JL, Hanna Jr MG. Current status of cancer immunodetection with radiolabeled human monoclonal antibodies.Semin Nucl Med 1993; 23: 165–179.

    Google Scholar 

  137. Bruland OS, Fodstad O, Aas M, Solheim OP, Hoie J, Skretting A, Winderen M, Michaelsen T, Pihl A. Immunoscintigraphy of bone sarcomas — results in 5 patients.Eur J Cancer 1994; 30A: 1484–1489.

    Google Scholar 

  138. Reilly RM. Immunoscintigraphy of tumours using99Tcm-labelled monoclonal antibodies: a review.Nucl Med Commun 1993; 14: 347–359.

    Google Scholar 

  139. Hoefnagel CA, Kapucu O, de Kraker J, van Dongen A, Voute PA. Radioimmunoscintigraphy using [111In]antimyosin Fab fragments for the diagnosis and follow-up of rhabdomyosarcoma.Eur J Cancer 1993; 29A: 2096–2100.

    Google Scholar 

  140. Kelly KM, Beverley PC, Chu AC, Davenport V, Gordon I, Smith M, Pritchard J. Successful in vivo immunolocalization of Langerhans cell histiocytosis with use of a monoclonal antibody, NA1/34.J Pediatr 1994; 125: 717–722.

    Google Scholar 

  141. Etoh T, Takahashi H, Maie M, Ohnuma N, Tanabe M. Tumor imaging by antineuroblastoma monoclonal antibody and its application to treatment.Cancer 1988; 62: 1282–1286.

    Google Scholar 

  142. Novak-Hofer I, Amstutz HP, Haldemann A, Blaser K, Morgenthaler JJ, Blauenstein P, Schubiger PA. Radioimmunolocalization of neuroblastoma xenografts with chimeric antibody chCE7.J Nucl Med 1992; 33: 231–236.

    Google Scholar 

  143. Yeh SD, Larson SM, Burch L, Kushner BH, Laquaglia M, Finn R, Cheung NK. Radioimmunodetection of neuroblastoma with iodine-131-3F8: correlation with biopsy, iodine-131-metaiodobenzylguanidine and standard diagnostic modalities.J Nucl Med 1991; 32: 769–776.

    Google Scholar 

  144. Handgretinger R, Anderson K, Lang P, Dopfer R, Klingebiel T, Schrappe M, Reuland P, Gillies SD, Reisfeld RA, Neithammer D. A phase I study of human/mouse chimeric antiganglioside GD2 antibody ch14.18 in patients with neuroblastoma.Eur J Cancer 1995; 31A: 261–267.

    Google Scholar 

  145. Strauss LG, Conti PS. The applications of PET in clinical oncology.J Nucl Med 1991; 32: 623–648.

    Google Scholar 

  146. Fischman AJ, Alpert NM. FDG-PET in oncology: there's more to it than looking at pictures [editorial; comment].J Nucl Med 1993; 34: 6–11.

    Google Scholar 

  147. Hawkins RA, Hoh C, Glaspy J, Choi Y, Dahlbom M, Rege S, Messa C, Nietszche E, Hoffman E, Seeger L, Maddahi J, Phelps ME. The role of positron emission tomography in oncology and other whole-body applications.Semin Nucl Med 1992; 22: 268–284.

    Google Scholar 

  148. Hoffman JM, Hanson MW, Coleman RE. Clinical positron emission tomography imaging.Radiol Clin North Am 1993; 31: 935–959.

    Google Scholar 

  149. Hoh CK, Hawkins RA, Glaspy JA et al. Cancer detection with whole-body PET using 2-[18F]fluoro-2-deoxy-d-glucose.J Comput Assist Tomogr 1993; 17: 582–589.

    Google Scholar 

  150. Hob CK, Dahlbom M, Hawkins RA, Glaspy JA, Yao WJ, Lee SJ, Maddahi J, Phelps ME. Basic principles of positron emission tomography in oncology: quantitation and whole body techniques.Wien Klin Wochenschr 1994; 106: 496–504.

    Google Scholar 

  151. Shields AF, Graham MM, Spence AM. The role of PET imaging in clinical oncology. A current status report. In: Freeman LM, ed.Nuclear medicine annual. New York: Raven Press; 1995: 129–168.

    Google Scholar 

  152. Hoffman JM, Hanson MW, Friedman HS, Hockenberger BM, Oakes WJ, Halperin EC, Coleman RE. FDG-PET in pediatric posterior fossa brain tumors.J Comput Assist Tomogr 1992; 16: 62–68.

    Google Scholar 

  153. Bruggers CS, Friedman HS, Fuller GN, Tien RD, Marks LB, Halperin EC, Hockenberger B, Oakes WJ, Hoffman JM. Comparison of serial PET and MRI scans in a pediatric patient with a brainstem glioma.Med Pediatr Oncol 1993; 21: 301–306.

    Google Scholar 

  154. O'Tuama LA, Phillips PC, Strauss LC, Carson BC, Uno Y, Smith QR, Dannals RF, Wilson AA, Ravert HT, Loats S, Loats HA, LaFrance ND, Wagner HN Jr. Two-phase [11C]L-methionine PET in childhood brain tumors.Pediatr Neurol 1990; 6: 163–170.

    Google Scholar 

  155. Shulkin BL, Koeppe RA, Francis IR, Deeb GM, Lloyd RV, Thompson NW. Pheochromocytomas that do not accumulate metaiodobenzylguanidine: localization with PET and administration of FDG.Radiology 1993; 186: 711–715.

    Google Scholar 

  156. Leskinen-Kallio S, Huovinen R, Nagren K, Lehikoinen P, Ruotsalainen U, Teras M, Joensuu H. [11C]methionine quantitation in cancer PET studies.J Comput Assist Tomogr 1992; 16: 468–474.

    Google Scholar 

  157. Ichiya Y, Kuwabara Y, Otsuka M, Tahara T, Yoshikai T, Fukumura T, Jingu K, Masuda K. Assessment of response to cancer therapy using fluorine-18-fluorodeoxyglucose and positron emission tomography.J Nucl Med 1991; 32: 1655–1660.

    Google Scholar 

  158. Okada J, Oonishi H, Yoshikawa K, Itami J, Uno K, Imaseki K, Arimizu N. FDG-PET for predicting the prognosis of malignant lymphoma.Ann Nucl Med 1994; 8: 187–191.

    Google Scholar 

  159. Okada J, Oonishi H, Yoshikawa K, Imaseki K, Uno K, Itami J, Arimizu N. FDG-PET for the evaluation of tumor viability after anticancer therapy.Ann Nucl Med 1994; 8: 109–113.

    Google Scholar 

  160. Lyall HA, Constant CR, Wraight EP. Case report: Ewing's sarcoma in distal tibial metaphysis mimicking osteomyelitis.Clin Radiol 1993; 48: 140–142.

    Google Scholar 

  161. Maurer A, Chen DC, Camargo E, Wong DF, Wagner H Jr, Alderson PO. Utility of three-phase skeletal scintigraphy in suspected osteomyelitis.J Nucl Med 1981; 22: 941–949.

    Google Scholar 

  162. Gilday DL, Paul DJ, Paterson J. Diagnosis of osteomyelitis in children by combined blood pool and bone imaging.Radiology 1975; 117: 331–335.

    Google Scholar 

  163. Tuson CE, Hoffman EB, Mann MD. Isotope bone scanning for acute osteomyelitis and septic arthritis in children.J Bone Joint Surg [Br] 1994; 76: 306–310.

    Google Scholar 

  164. Rosovsky M, FitzPatrick M, Goldfarb CR, Finestone H. Bilateral osteomyelitis due to intraosseous infusion: case report and review of the English-language literature.Pediatr Radiol 1994; 24: 72–73.

    Google Scholar 

  165. Rosovsky M, Goldfarb CR, Finestone H, Ongseng F. “Cold spots” in pediatric bone imaging.Semin Nucl Med 1994; 24: 184–186.

    Google Scholar 

  166. Barron BJ, Tran HD, Lamki LM. Scintigraphic findings of osteomyelitis after intraosseous infusion in a child.Clin Nucl Med 1994; 19: 307–308.

    Google Scholar 

  167. Howman-Giles R, Uren R. Multifocal osteomyelitis in childhood. Review by radionuclide bone scan.Clin Nucl Med 1992; 17: 274–278.

    Google Scholar 

  168. Pijpers R, Ekkelkamp S, Roos JC, Teule GJ. Reduced perfusion and uptake of99mTc HDP in the iliac bone. A rare presentation of pelvic osteomyelitis.Clin Nucl Med 1994; 19: 516–518.

    Google Scholar 

  169. Sziklas JJ, Rosenberg RJ, Weiner RE, Spencer RP. Photopenic to avid radiogallium transition after rupture of the marrow cavity in acute femoral osteomyelitis.Clin Nucl Med 1992; 17: 328–329.

    Google Scholar 

  170. Schauwecker DS. The scintigraphic diagnosis of osteomyelitis [review].Am J Roentgenol 1992; 158: 9–18.

    Google Scholar 

  171. Alazraki NP. Radionuclide imaging in the evaluation of infections and inflammatory disease [review].Radiol Clin North Am 1993; 31: 783–794.

    Google Scholar 

  172. Traughber PD, Manaster BJ, Murphy K, Alazraki NP. Negative bone scans of joints after aspiration or arthrography: experimental studies.Am J Roentgenol 1986; 146: 87–91.

    Google Scholar 

  173. Canale ST, Harkness RM, Thomas PA, Massie JD. Does aspiration of bones and joints affect results of later bone scanning?J Pediatr Orthop 1985; 5: 23–26.

    Google Scholar 

  174. Mandell GA, Harcke HT, Bowen JR, Sharkey CA. Transient photopenia of the femoral head following arthrography.Clin Nucl Med 1986; 14: 397–404.

    Google Scholar 

  175. Lantto T, Kaukonen JP, Kokkola A, Laitinen R, Vorne M.99mTc HMPAO labeled leukocytes superior to bone scan in the detection of osteomyelitis in children.Clin Nucl Med 1992; 17: 7–10.

    Google Scholar 

  176. Peters AM. The utility of [99mTc]HMPAO-leukocytes for imaging infection.Semin Nucl Med 1994; 24: 110–127.

    Google Scholar 

  177. Palestro CJ. The current role of gallium imaging in infection.Semin Nucl Med 1994; 24: 128–141.

    Google Scholar 

  178. Gainey MA, Siegel JA, Smergel EM, Jara BJ. Indium-111 labeled white blood cells: dosimetry in children.J Nucl Med 1988; 29: 689–694.

    Google Scholar 

  179. Datz FL. Indium-111-labeled leukocytes for the detection of infection: current status.Semin Nucl Med 1994; 24: 92–109.

    Google Scholar 

  180. Rubin RH, Fischman AJ, Callahan RJ, Khaw BA, Keech F, Ahmad M, Wilkinson R, Strauss HW. 111In-labeled nonspecific immunoglobulin scanning in the detection of focal infection.N Engl J Med 1989; 321: 935–940.

    Google Scholar 

  181. Rubin RH, Fischman AJ. The use of radiolabeled nonspecific immunoglobulin in the detection of focal inflammation.Semin Nucl Med 1994; 24: 169–179.

    Google Scholar 

  182. Becker W, Goldenberg DM, Wolf F. The use of monoclonal antibodies and antibody fragments in the imaging of infectious lesions.Semin Nucl Med 1994; 24: 142–153.

    Google Scholar 

  183. Fischman AJ, Babich JW, Rubin RH. Infection imaging with technetium-99m-labeled chemotactic peptide analogs.Semin Nucl Med 1994; 24: 154–168.

    Google Scholar 

  184. Rusckowski M, Fritz B, Hnatowich DJ. Localization of infection using streptavidin and biotin: an alternative to nonspecific polyclonal immunoglobulin.J Nucl Med 1992; 33: 1810–1815.

    Google Scholar 

  185. Buscombe JR, Oyen WJG, Corstens FHM, Ell PJ, Miller RF. Localization of infection in HIV antibody positive patients with fever. Comparison of the efficacy of67Ga citrate and radiolabeled human IgG.Clin Nucl Med 1995; 20: 334–339.

    Google Scholar 

  186. Ash J, Gilday DL. The futility of bone scanning in neonatal osteomyelitis: concise communication.J Nucl Med 1980; 21: 417–420.

    Google Scholar 

  187. Bressler EL, Conway JJ, Weiss SC. Neonatal osteomyelitis examined by bone scintigraphy.Radiology 1984; 152: 685–688.

    Google Scholar 

  188. al-Nahhas AM. Three-phase bone scans and neonatal osteomyelitis [letter; comment].Nucl Med Commun 1994; 15: 774–775.

    Google Scholar 

  189. Oestreich AE. Imaging of the skeleton and soft tissue in children.Curr Opin Radiol 1991; 3: 889–894.

    Google Scholar 

  190. Conway JJ, Collins M, Tanz RR, Radkowski MA, Annandappa E, Hernandez R, Freeman EL. The role of bone scintigraphy in detecting child abuse [review].Semin Nucl Med 1993; 23: 321–333.

    Google Scholar 

  191. Sty JR, Wells RG. Child abuse. Extraosseous abdominal bone imaging uptake.Clin Nucl Med 1994; 19: 1011.

    Google Scholar 

  192. Simonian PT, Vahey JW, Rosenbaum DM, Mosca VS, Staheli LT. Fracture of the cuboid in children. A source of leg symptoms.J Bone Joint Surg [Br] 1995; 77: 104–106.

    Google Scholar 

  193. Sty JR, Wells RG, Smith WB. The child with acute leg pain.Heart Lung 1988; 17: 371–373.

    Google Scholar 

  194. Donati RB, Echo BS, Powell CE. Bilateral tibial stress fractures in a six-year-old male. A case report.Am J Sports Med 1990; 18: 323–325.

    Google Scholar 

  195. Singer A, Ben-Yehuda O, Ben-Ezra Z, Zaltzman S. Multiple identical stress fractures in monozygotic twins. Case report.J Bone Joint Surg [Am] 1990; 72: 444–445.

    Google Scholar 

  196. Horev G, Korenreich L, Ziv N, Grunebaum M. The enigma of stress fractures in the pediatric age: clarification or confusion through the new imaging modalities.Pediatr Radiol 1990; 20: 469–471.

    Google Scholar 

  197. Wahner HW, Fogelman I.The evaluation of osteoporosis: dual energy x-ray absorptiometry in clinical practice. London: Dunitz, 1994.

    Google Scholar 

  198. Faulkner RA, Bailey DA, Drinkwater DT, Wilkinson AA, Houston CS, McKay HA. Regional and total body bone mineral content, bone mineral density, and total body tissue composition in children 8–16 years of age.Calcif Tissue Int 1993; 53: 7–12.

    Google Scholar 

  199. Venkataraman PS, Ahluwalia BW. Total bone mineral content and body composition by x-ray densitometry in newborns.Pediatrics 1992; 90: 767–770.

    Google Scholar 

  200. Gordon CL, Webber CE. Body composition and bone mineral distribution during growth in females.Can Assoc Radiol J 1993; 44: 112–116.

    Google Scholar 

  201. Kao CH, Chen CC, Wang SJ, Yeh SH. Bone mineral density in children with Down's syndrome detected by dual photon absorptiometry.Nucl Med Commun 1992; 13: 773–775.

    Google Scholar 

  202. Sugimoto T, Nishino M, Tsunenari T, Kawakatsu M, Shimogaki K, Fujii Y, Negishi H, Tsutsumi M, Fukase M, Chihara K. Radial bone mineral content of normal Japanese infants and prepubertal children: influence of age, sex and body size.Bone Miner 1994; 24: 189–200.

    Google Scholar 

  203. Bell NH, Shary J, Stevens J, Garza M, Gordon L, Edwards J. Demonstration that bone mass is greater in black than in white children.J Bone Miner Res 1991; 6: 719–723.

    Google Scholar 

  204. del Rio L, Carrascosa A, Pons F, Gusinye M, Yeste D, Domenech FM. Bone mineral density of the lumbar spine in white Mediterranean Spanish children and adolescents: changes related to age, sex, and puberty.Pediatr Res 1994; 35: 362–366.

    Google Scholar 

  205. Katzman DK, Bachrach LK, Carter DR, Marcus R. Clinical and anthropometric correlates of bone mineral acquisition in healthy adolescent girls.J Clin Endocrinol Metab 1991; 73: 1332–1339.

    Google Scholar 

  206. Proesmans W, Goos G, Emma F, Geusens P, Nijs J, Dequeker J. Total body mineral mass measured with dual photon absorptiometry in healthy children.Eur J Pediatr 1994; 153: 807–812.

    Google Scholar 

  207. Turner JG, Gilchrist NL, Ayling EM, Hassall AJ, Hooke EA, Sadler WA. Factors affecting bone mineral density in high school girls.N Z Med J 1992; 105: 95–96.

    Google Scholar 

  208. Ilich JZ, Hsieh LC, Tzagournis MA, Wright JK, Saracoglu M, Barden HS, Matkovic V. A comparison of single-photon and dual X-ray absorptiometry of the forearm in children and adults.Bone 1994; 15: 187–191.

    Google Scholar 

  209. Kinberg KA, Hopp RJ, Biven RE, Gallagher JC. Bone mineral density in normal and asthmatic children.J Allergy Clin Immunol 1994; 94: 490–497.

    Google Scholar 

  210. Warady BD, Lindsley CB, Robinson RG, Lukert BP. Effects of nutritional supplementation on bone mineral status of children with rheumatic diseases receiving corticosteroid therapy.J Rheumatol 1994; 21: 530–535.

    Google Scholar 

  211. Guichot Garcia R, Lluch Fernandez D, Ramos Sanchez I. Evaluation of the bone mass by dual-photon absorptiometry in children under prolonged anticonvulsant therapy (in spanish).An Esp Pediatr 1992; 37: 109–113.

    Google Scholar 

  212. Chung S, Ahn C. Effects of anti-epileptic drug therapy on bone mineral density in ambulatory epileptic children.Brain Dev 1994; 16: 382–385.

    Google Scholar 

  213. Kaplan FS, August CS, Dalinka MK, Karp J, Fallon MD, Haddad JG. Bone densitometry observations of osteopetrosis in response to bone marrow transplantation.Clin Orthop 1993; 294: 79–84.

    Google Scholar 

  214. Thomas KA, Cook SD, Skalley TC, Renshaw SV, Makuch RS, Gross M, Whitecloud TS, Bennett JT. Lumbar spine and femoral neck bone mineral density in idiopathic scoliosis: a follow-up study.J Pediatr Orthop 1992; 12: 235–240.

    Google Scholar 

  215. Neely EK, Marcus R, Rosenfeld RG, Bachrach LK. Turner syndrome adolescents receiving growth hormone are not osteopenic.J Clin Endocrinol Metab 1993; 76: 861–866.

    Google Scholar 

  216. Ponder SW, McCormick DP, Fawcett HD, Tran AD, Ogelsby GW, Brouhard BH, Travis LB. Bone mineral density of the lumbar vertebrae in children and adolescents with insulin-dependent diabetes mellitus.J Pediatr 1992; 120: 541–545.

    Google Scholar 

  217. Hergenroeder AC. Bone mineralization, hypothalamic amenorrhea, and sex steroid therapy in female adolescents and young adults.J Pediatr 1995; 126: 683–689.

    Google Scholar 

  218. Ghahremani GG. Radiology of Meckel's diverticulum.Crit Rev Diagn Imaging 1986; 26: 1–43.

    Google Scholar 

  219. Kusumoto H, Yoshida M, Takahashi I, Anai H, Maehara Y, Sugimachi K. Complications and diagnosis of Meckel's diverticulum in 776 patients.Am J Surg 1992; 164: 382–383.

    Google Scholar 

  220. Huang CS, Lin LH. Laparoscopic Meckel's diverticulectomy in infants: report of three cases.J Pediatr Surg 1993; 28: 1486–1489.

    Google Scholar 

  221. Heinzelmann M, Schob O, Schlumpf R, Decurtins M, Himmelmann A, Largiader F. Preoperative diagnosis of Meckel's diverticulum by pertechnetate scan and laparoscopic resection.Surg Laparosc Endosc 1994; 4: 378–381.

    Google Scholar 

  222. Sfakianakis GN, Conway JJ. Detection of ectopic gastric mucosa in Meckel's diverticulum and in other aberrations by scintigraphy. II. Indications and methods — a 10 year experience.J Nucl Med 1981; 22: 732–738.

    Google Scholar 

  223. Imaeda T, Kanematsu M, Sone Y, Iinuma G, Hirose Y, Miya K, Shimokawa K. A case of intermittent bleeding Meckel's diverticulum.Ann Nucl Med 1990; 4: 107–110.

    Google Scholar 

  224. Datz FL, Christian PE, Hutson WR, Moore JG, Morton KA. Physiological and pharmacological interventions in radionuclide imaging of the tubular gastrointestinal tract.Semin Nucl Med 1991; 21: 140–152.

    Google Scholar 

  225. Heyman S. Meckel's diverticulum: possible detection by combining pentagastrin with histamine H2 receptor blocker.J Nucl Med 1994; 35: 1656–1658.

    Google Scholar 

  226. Demirkol O, Adalet I, Boneval C, Cantez S. Visualization of a perforated small bowel duplication during Meckel's scintigraphy.Clin Nucl Med 1995; 20: 111–113.

    Google Scholar 

  227. Burke G, Mercado-Deane MG, Burton EM. Organoaxial gastric volvulus detected by Meckel scan.Clin Nucl Med 1994; 19: 598–599.

    Google Scholar 

  228. Yen CK, Lanoie Y. Effect of stannous pyrophosphate red blood cell gastrointestinal bleeding scan on subsequent Meckel's scan.Clin Nucl Med 1992; 17: 454–456.

    Google Scholar 

  229. Gaskin KJ, Waters DL, Howman-Giles R, de Silva M, Earl JW, Martin HC, Kan AE, Brown JM, Dorney SF. Liver disease and common-bile-duct stenosis in cystic fibrosis.N Engl J Med 1988; 318: 340–346.

    Google Scholar 

  230. Nagel RA, Westaby D, Javaid A, Kavani J, Meire HB, Lombard MG, Wise A, Williams R, Hodson ME. Liver disease and bile duct abnormalities in adults with cystic fibrosis.Lancet 1989; II: 1422–1425.

    Google Scholar 

  231. O'Brien S, Keogan M, Casey M, Duffy G, McErlean D, Fitzgerald MX, Hegarty JE. Biliary complications of cystic fibrosis.Gut 1992; 33: 387–391.

    Google Scholar 

  232. Dogan AS, Conway JJ, Lloyd-Still JD. Hepatobiliary scintigraphy in children with cystic fibrosis and liver disease.J Nucl Med 1994; 35: 432–435.

    Google Scholar 

  233. Colombo C, Castellani MR, Balistreri WF, Seregni E, Assaisso ML, Giunta A. Scintigraphic documentation of an improvement in hepatobiliary excretory function after treatment with ursodeoxycholic acid in patients with cystic fibrosis and associated liver disease.Hepatology 1992; 15: 677–684.

    Google Scholar 

  234. Fig LM, Daugherty D, Nostrant T, Shapiro B. Common bile duct obstruction in cystic fibrosis: utility of hepatobiliary scintigraphy.Am J Physiol Imaging 1991; 6: 194–196.

    Google Scholar 

  235. Waldman JD, Rosenthal A, Smith AL, Shurin S, Nadas AS. Sepsis and congenital asplenia.J Pediatr 1977; 90: 555–559.

    Google Scholar 

  236. Armas RR. Clinical studies with spleen-specific radiolabeled agents.Semin Nucl Med 1985; 15: 260–275.

    Google Scholar 

  237. Sty JR, Conway JJ. The spleen: development and functional evaluation.Semin Nucl Med 1985; 15: 276–298.

    Google Scholar 

  238. Kirks DR, ed.Practical pediatric imaging. Boston: Little, Brown and Company, 1991.

    Google Scholar 

  239. Carty H, Brunelle F, Shaw D, Kendall B.Imaging children. Edinburgh: Churchill Livingstone, 1994.

    Google Scholar 

  240. Feld LG. Urinary tract infections in childhood: definition, pathogenesis, diagnosis, and management [review].Pharmacotherapy 1991; 11: 326–335.

    Google Scholar 

  241. Hodson CJ. Reflux nephropathy: a personal historical review.AJR Am J Roentgenol 1981; 137: 451–462.

    Google Scholar 

  242. Lebowitz RL, Olbing H, Parkkulainen KV, Smellie JM, Tammuren-Mobius TE. International system of radiographic grading of vesicoureteric reflux.Pediatr Radiol 1985; 15: 105–109.

    Google Scholar 

  243. Eggli DF, Tulchinsky M. Scintigraphic evaluation of pediatric urinary tract infection [review].Semin Nucl Med 1993; 23: 199–218.

    Google Scholar 

  244. Wyly JB, Lebowitz RL. Refluxing urethral ectopic ureters: recognition by the cyclic voiding cystourethrogram.AJR Am J Roentgenol 1984; 142: 1263–1267.

    Google Scholar 

  245. Jequier S, Jequier JC. Reliability of voiding cystourethrography to detect reflux.AJR Am J Roentgenol 1989; 153: 807–810.

    Google Scholar 

  246. Fettich JJ, Kenda RB. Cyclic direct radionuclide voiding cystography: increasing reliability in detecting vesicoureteral reflux in children.Pediatr Radiol 1992; 22: 337–338.

    Google Scholar 

  247. Paltiel HJ, Rupich RC, Kiruluta HG. Enhanced detection of vesicoureteral reflux in infants and children with use of cyclic voiding cystourethrography.Radiology 1992; 184: 753–755.

    Google Scholar 

  248. Gelfand MJ, Koch BL, Gylys-Morin VM, Elgazzar AH, Torgerson CL. Cyclic cystography: diagnostic yield in selected pediatric populations [abstract].J Nucl Med 1995; 36: 33P.

    Google Scholar 

  249. Ditchfield MR, de Campo JF, Nolan TM, Cook DJ, Grimwood K, Powell HR, Sloane R, Cahill S. Risk factors in the development of early renal cortical defects in children with urinary tract infection.AJR Am J Roentgenol 1994; 162: 1393–1397.

    Google Scholar 

  250. Ditchfield MR, De Campo JF, Cook DJ, Nolan TM, Powell HR, Sloane R, Grimwood K, Cahill S. Vesicoureteral reflux: an accurate predictor of acute pyelonephritis in childhood urinary tract infection?Radiology 1994; 190: 413–415.

    Google Scholar 

  251. Majd M, Rushton HG, Jantausch B, Wiedermann BL. Relationship among vesicoureteral reflux, P-fimbriatedEscherichia coli, and acute pyelonephritis in children with febrile urinary tract infection.J Pediatr 1991; 1 19: 578–585.

    Google Scholar 

  252. Gleeson FV, Gordon I. Imaging in urinary tract infection.Arch Dis Child 1991; 66: 1282–1283.

    Google Scholar 

  253. Conway JJ. The role of scintigraphy in urinary tract infection.Urol Radiol 1988; 10: 207–209.

    Google Scholar 

  254. Verboven M, Ingels M, Delree M, Piepsz A. 99mTc-DMSA scintigraphy in acute urinary tract infection in children.Pediatr Radiol 1990; 20: 540–542.

    Google Scholar 

  255. Majd M, Rushton HG. Renal cortical scintigraphy in the diagnosis of acute pyelonephritis.Semin Nucl Med 1992; 22: 98–111.

    Google Scholar 

  256. Elison BS, Taylor D, Van der Wall H, Pereira JK, Cahill S, Rosenberg AR, Farnsworth RH, Murray IP. Comparison of DMSA scintigraphy with intravenous urography for the detection of renal scarring and its correlation with vesicoureteric reflux.Br J Urol 1992; 69: 294–302.

    Google Scholar 

  257. Jakobsson B, Soderlundh S, Berg U. Diagnostic significance of99mTc-dimercaptosuccinic acid (DMSA) scintigraphy in urinary tract infection.Arch Dis Child 1992; 67: 1338–1342.

    Google Scholar 

  258. Buyan N, Bircan ZE, Hasanoglu E, Ozturk E, Bayhan H, Rota S. The importance of99mTc DMSA scanning in the localization of childhood urinary tract infections.Int Urol Nephrol 1993; 25: 11–17.

    Google Scholar 

  259. Dacher JN, Boillot B, Eurin D, Marguet C, Mitrofanoff P, Le Dosseur P. Rational use of CT in acute pyelonephritis: findings and relationships with reflux.Pediatr Radiol 1993; 23: 281–285.

    Google Scholar 

  260. Mouratidis B, Ash JM, Gilday DL. Comparison of planar and SPECT99Tcm-DMSA scintigraphy for the detection of renal cortical defects in children.Nucl Med Commun 1993; 14: 82–86.

    Google Scholar 

  261. Majd M, Rushton G, Chandra R, Andrich M, Tardif C, Rashti F. Tc-99m DMSA renal cortical scintigraphy for the detection of acute pyelonephritis in piglets: comparison of planar and SPECT imaging [abstract].Eur J Nucl Med 1994; 21 [Suppl]: S88.

    Google Scholar 

  262. Connolly LP, Treves ST, Connolly SA, Buff B, Applegate KA, Davis RT, Zurakowski D. Comparison between planar, pinhole and SPECT Tc-99m DMSA imaging for the detection of renal cortical defects [abstract].J Nucl Med 1995; 36: 32P.

  263. Jadresic L, Cartwright K, Cowie N, Witcombe B, Stevens D. Investigation of urinary tract infection in childhood.BMJ 1993; 307: 761–764.

    Google Scholar 

  264. Devous MD, Leroy RF, Homan RW. Single-photon emission computed tomography in epilepsy.Semin Nucl Med 1990; 20: 325–341.

    Google Scholar 

  265. Carrilho PG, Yacubian EM, Cukiert A, Fiore LA, Buchpiguel CA, Jorge CL, Scapolan HB, Bacheschi LA, Marino Jr R. MRI and brain spect findings in patients with unilateral temporal lobe epilepsy and normal CT scan.Arq Neuropsiquiatr 1994; 52: 149–152.

    Google Scholar 

  266. Feggi L, Scarpa P, Calzolari F. Tc-99m HMPAO brain scintigraphy in children with partial epilepsy.Clin Nucl Med 1995; 20: 42–45.

    Google Scholar 

  267. Spina A, Damato R, Losito R, Marzocco PL, Zizzo L, Damato V. Correlations between abnormalities on brain SPECT scan and interictal EEG-foci in children with ‘intractable’ partial epilepsy.Acta Neurol (Napoli) 1993; 15: 321–327.

    Google Scholar 

  268. Wieser HG. PET and SPECT in epilepsy.Eur Neurol 1994; 34 Suppl 1: 58–62.

    Google Scholar 

  269. Zubal IG, Spencer SS, Imam K, Seibyl J, Smith EO, Wisniewski G, Hoffer PB. Difference images calculated from ictal and interictal technetium-99m-HMPAO SPECT scans of epilepsy.J Nucl Med 1995; 36: 684–689.

    Google Scholar 

  270. Janicek MJ, O'Tuama LA, Treves ST. Quantitative evaluation of99mTc-hexamethylpropylenamineoxime brain SPECT in childhood-onset epilepsy.J Nucl Biol Med 1992; 36: 319–323.

    Google Scholar 

  271. Grunwald F, Menzel C, Pavics L, Bauer J, Hufnagel A, Reichmann K, Sakowski R, Elger CE, Biersack HJ. Ictal and interictal brain SPECT imaging in epilepsy using technetium-99m-ECD.J Nucl Med 1994; 35: 1896–1901.

    Google Scholar 

  272. Carmant L, O'Tuama LA, Roach PJ, Kramer U, Mikati MA, Riviello JJ, Helmers SL, Madsen JR, Black PM, Lombroso CT, Treves ST, Holmes GL. Technetium-99m HmPAO brain SPECT and outcome of hemispherectomy for intractable seizures.Pediatr Neurol 1994; 11: 203–207.

    Google Scholar 

  273. Majeed-Saidan MA, Joyce B, Khan M, Hamam HD. Congenital hypothyroidism: the Riyadh Military Hospital experience.Clin Endocrinol (Oxf) 1993; 38: 191–195.

    Google Scholar 

  274. Paltiel HJ, Summerville DA, Treves ST. Iodine-123 scintigraphy in the evaluation of pediatric thyroid disorders: a ten year experience.Pediatr Radiol 1992; 22: 251–256.

    Google Scholar 

  275. Warnakulasuriya KA, Herath KB. Investigating a lingual thyroid.Int J Oral Maxillofac Surg 1992; 21: 227–229.

    Google Scholar 

  276. Wells RG, Sty JR, Duck SC. Technetium 99m pertechnetate thyroid scintigraphy: congenital hypothyroid screening.Pediatr Radiol 1986; 16: 368–373.

    Google Scholar 

  277. Hsu CY, Wang SJ. Thyroid hemiagenesis accompanying an ectopic sublingual thyroid.Clin Nucl Med 1994; 19: 546.

    Google Scholar 

  278. Misaki T, Koh T, Shimbo S, Kasagi K, Konishi J. Dual-site thyroid ectopy in a mother and son.Thyroid 1992; 2: 325–327.

    Google Scholar 

  279. Larar GN, O'Tuama LA, Treves ST. Nuclear medicine in the pediatric chest.Radiol Clin North Am 1993; 31: 481–498.

    Google Scholar 

  280. Worsley DF, Alavi A, Palevsky HI. Role of radionuclide imaging in patients with suspected pulmonary embolism.Radiol Clin North Am 1993; 31: 849–858.

    Google Scholar 

Download references

Author information

Affiliations

  1. Division of Nuclear Medicine, Department of Radiology, British Columbia's Children's Hospital, 4480 Oak Street, V6H 3V4, Vancouver, British Columbia, Canada

    Helen R. Nadel

Authors
  1. Helen R. Nadel
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Nadel, H.R. Where are we with nuclear medicine in pediatrics?. Eur J Nucl Med 22, 1433–1451 (1995). https://doi.org/10.1007/BF01791153

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01791153

Key words

  • Pediatric nuclear medicine
  • State of the art
  • Imaging advances